STAT3 and hepatocellular carcinoma: In HCC, iCAF‐derived IL‐6 upregulates PD‐1 expression on CD8+ T cells and induces PD‐L1 expression on neutrophils by activating the STAT3 signaling pathway, ultimately impairing T‐cell function and inducing immune tolerance [92].